ArisGlobal Logo
Nippon Shinyaku, a prominent Japanese pharmaceutical company, has selected LifeSphere® Safety, a comprehensive safety platform developed by ArisGlobal, to improve its case processing and safety data management. This decision, announced on October 28, 2025, aims to unify and streamline the company’s global and domestic safety processes through a single database.
The adoption of LifeSphere® Safety marks a significant step for Nippon Shinyaku, as it seeks to enhance operational efficiency while ensuring compliance with both local and international regulations. The platform’s features include LifeSphere® MultiVigilance, which offers end-to-end case processing, and LifeSphere® Business Intelligence, a robust analytics solution that provides real-time insights into safety operations. Additionally, LifeSphere® Reporter facilitates multilingual reporting, enabling the timely capture of critical safety data from sales representatives and affiliates worldwide.
In her statement, Ms. Hitomi Kimura, Director of Resource Procurement, Production & Assurance at Nippon Shinyaku, expressed enthusiasm for the collaboration: “We are pleased to begin our collaboration with ArisGlobal by adopting LifeSphere Safety. This transition will allow us to increase efficiency, reduce external costs, and gain clearer visibility into global safety data, all while ensuring compliance across our operations.”
Nippon Shinyaku’s selection of LifeSphere reflects a broader trend among life sciences organizations in Japan and globally, who are increasingly seeking platforms that enhance operational efficiency and lay a strong foundation for future innovations. Zhiyi Chen, Senior Vice President for the Asia-Pacific region at ArisGlobal, noted, “Nippon Shinyaku’s move to LifeSphere reflects a growing demand from Japanese and global life sciences organizations for platforms that deliver efficiency today while creating a strong foundation for future innovation.”
This partnership builds on ArisGlobal’s recent momentum in the Asia-Pacific region, where the company reported a remarkable 233% year-over-year increase in LifeSphere implementations.
ArisGlobal, headquartered in the United States, specializes in AI-driven technology for the life sciences sector, aiming to transform how companies develop and bring new products to market. With regional offices in Europe, India, Japan, and China, the company is positioned to support organizations like Nippon Shinyaku in their pursuit of operational excellence.
For more information about Nippon Shinyaku and its commitment to developing innovative medicines, visit their official website at Nippon Shinyaku. For updates on ArisGlobal, follow them on LinkedIn or visit their website at ArisGlobal.
